INGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Inogen Inc
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$6.55+0.30 (+4.80%)
Close on Oct 19, 2026
- Market cap
- $177.15M
- P/E (TTM)
- –
- Dividend yield
- –
Inogen statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Orthopedic, Prosthetic & Surgical Appliances & Supplies companies for comparison
Valuation
| Measure | Inogen | Industry median |
|---|---|---|
| Market Cap | $173.83M | $230.55M |
| Enterprise Value | $68.29M | $202.97M |
| PS Ratio | 0.49 | 3.11 |
| PB Ratio | 0.99 | 3.14 |
| P/TBV Ratio | 1.27 | 4.57 |
Enterprise value
| Measure | Inogen | Industry median |
|---|---|---|
| EV / Sales | 0.19 | 2.92 |
Income (trailing twelve months)
| Measure | Inogen | Industry median |
|---|---|---|
| Revenue | $354.30M | $102.39M |
| Gross Profit | $157.69M | $60.36M |
| Operating Income | -$30.85M | -$4.31M |
| Pretax Income | -$25.31M | -$2.26M |
| Net Income | -$24.60M | -$6.57M |
| EBITDA | -$13.54M | -$1.98M |
| EPS (Diluted) | -$0.90 | -$0.07 |
Margins
| Measure | Inogen | Industry median |
|---|---|---|
| Gross Margin | 44.5% | 55.1% |
| Operating Margin | -8.71% | -6.04% |
| Pretax Margin | -7.14% | -4.11% |
| Profit Margin | -6.94% | -10.5% |
| EBITDA Margin | -3.82% | -2.67% |
| FCF Margin | -1.41% | -0.30% |
Returns
| Measure | Inogen | Industry median |
|---|---|---|
| Return on Equity (ROE) | -13.1% | -19.2% |
| Return on Assets (ROA) | -8.23% | -13.3% |
| Return on Invested Capital (ROIC) | -33.3% | -4.11% |
| Return on Capital Employed (ROCE) | -14.4% | -9.07% |
Growth
| Measure | Inogen | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 3.15% | 8.85% |
| Revenue Growth (3Y CAGR) | -2.59% | 7.08% |
| Revenue Growth (5Y CAGR) | 2.48% | 11.8% |
Balance sheet
| Measure | Inogen | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $105.54M | $37.33M |
| Net Cash (Debt) | $105.54M | $3.92M |
| Net Cash Per Share | $3.98 | $0.28 |
| Equity (Book Value) | $174.86M | $57.36M |
| Book Value Per Share | $6.59 | $2.81 |
| Tangible Book Value | $137.02M | $10.71M |
| Working Capital | $123.27M | $54.64M |
Financial position
| Measure | Inogen | Industry median |
|---|---|---|
| Current Ratio | 2.74 | 2.50 |
| Quick Ratio | 2.14 | 1.54 |
Cash flow (trailing twelve months)
| Measure | Inogen | Industry median |
|---|---|---|
| Operating Cash Flow | -$2.52M | -$653.46K |
| Capital Expenditures | -$2.47M | -$3.69M |
| Free Cash Flow | -$4.98M | -$835.02K |
| FCF Per Share | -$0.19 | -$0.02 |
Efficiency
| Measure | Inogen | Industry median |
|---|---|---|
| Asset Turnover | 1.19 | 0.59 |
| Inventory Turnover | 7.43 | 2.21 |
| Revenue Per Employee | $1.13M | $322.57K |
| Profits Per Employee | -$78.33K | -$51.88K |
| Employee Count | 314 | 185 |
Dividends and yields
| Measure | Inogen | Industry median |
|---|---|---|
| Earnings Yield | -14.1% | -6.91% |
| FCF Yield | -2.87% | -0.56% |
Shares
| Measure | Inogen | Industry median |
|---|---|---|
| Shares Outstanding | 26,538,300 | 44,856,700 |
| Shares Change (YoY) | 8.92% | 3.35% |
| Shares Change (QoQ) | -2.32% | 0.27% |
| Float | 25,564,100 | 37,097,900 |
| Shares Held by Insiders | 3.67% | 10.6% |
| Shares Held by Institutions | 72.9% | 63.5% |
Taxes
| Measure | Inogen | Industry median |
|---|---|---|
| Income Tax | -$710.00K | $1.52M |
Scores
| Measure | Inogen | Industry median |
|---|---|---|
| Altman Z-Score | 1.42 | 1.95 |
| Piotroski F-Score | 5 | 5 |
| Beneish M-Score | -2.32 | -2.64 |
Calculated by StockData from Inogen's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.